BMI	Body Mass Index
BP	Blood Pressure
cAMP	Cyclic adenosine monophosphate
CI	Confidence Interval
CNS	Central Nervous System
CV	Cardiovascular
CVOT	Cardiovascular Outcome Trials
DPP-4	Dipeptidyl-peptidase-4
EAT	Epicardial Adipose Tissue
eGFR	Estimated Glomerular Filtration Rate
GIP	Glucose-dependent Insulinotropic Polypeptide
GLP-1	Glucagon-like peptide-1
GLP-1 RAs	Glucagon-like peptide-1 receptor agonists
HF	Heart Failure
HFrEF	Heart Failure with Reduced Ejection Fraction
HFpEF	Heart Failure with Preserved Ejection Fraction
HHF	Hospitalization for Heart Failure
HR	Heart Rate
KCCQ-CSS	Kansas City Cardiomyopathy Questionnaire—Clinical Summary Score
LVEF	Left Ventricle Ejection Fraction
MACE	Major Adverse Cardiovascular Event
RAAS	Renin–Angiotensin–Aldosteron System
RCT	Randomized Clinical Trials
T2D	Type 2 Diabetes Mellitus
VT	Ventricular Tachycardia